Skip to Main Content

Paper Details

Incidence of brain metastases in patients with early HER2-positive breast cancer receiving neoadjuvant chemotherapy with trastuzumab and pertuzumab.
NPJ Breast Cancer
8
2022
BM, HER2, HER2-positive breast cancer, brain metastases, pCR, patients, pertuzumab, positive breast cancer, trastuzumab
Author NameAffiliation
Hannah Y WenMemorial Sloan Kettering Cancer Center
Larry NortonMemorial Sloan Kettering Cancer Center, Weill Cornell Medicine College
Larry NortonMemorial Sloan Kettering Cancer Center, Weill Cornell Medicine College
  • 1 - 3

Datasets

Release 1.2